AURKA and breast carcinoma: To assess if AurkA may promote a more aggressive phenotype in vivo, we isolated primary breast cancer cells (named KBr1, KBr2, KBr3 and KBr4) from 4 different mastectomized breast cancer patients and injected them into immune-compromised mice.